Josh Baltzell

Managing Director

josh@splitrock.com

Josh Baltzell joined Split Rock Partners at the firm's inception as a Principal with the healthcare investment team. He provides the healthcare team with an extensive background in the medical device industry, having been involved in virtually all aspects from product development to the acquisition and sale of mature organizations.

Prior to joining Split Rock Partners, Josh served as a Principal with St. Paul Venture Capital's healthcare team, which he joined in 2002. He joined St. Paul Venture Capital from Piper Jaffray where he held the position of vice president in the healthcare investment banking group. During his tenure there, he was involved in a broad range of investment banking activities including private and public equity financings as well as mergers and acquisitions on the buy and sell side.

Prior to joining Piper Jaffray, Josh spent more than seven years in various marketing and business development positions in the medical device industry including vice president, marketing and business development for a medical device start-up and group product manager - emerging technologies for SCIMED/Boston Scientific.

Josh graduated from St. Olaf College and has an MBA from the University of Minnesota's Carlson School of Management.

Josh's portfolio companies include:

Josh Baltzell
Assistant's name
Maria Agcaoili
Assistant's phone
(650) 617-1504
Assistant's email
maria@splitrock.com

Healthcare Portfolio Companies

Medical Devices

Status
  • Emphasys Medical

    Emphasys Medical - Redwood City, CA
    Minimally invasive device therapies to treat Chronic Obstructive Pulmonary Disease

    Private

  • Entellus Medical

    Entellus Medical - Maple Grove, MN
    Unique solutions to the unmet clinical needs of the ENT physician

    Private

  • Mirabilis

    Mirabilis Medica - Bothell, WA
    Therapeutic ultrasound devices for women's health

    Private

Other Healthcare

Status
  • Skin Medica

    SkinMedica - Carlsbad, CA
    Novel, proprietary prescription and non-prescription products for the dermatology market

    Private